pubmed-article:21165996 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21165996 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:21165996 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
pubmed-article:21165996 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
pubmed-article:21165996 | lifeskim:mentions | umls-concept:C0205054 | lld:lifeskim |
pubmed-article:21165996 | lifeskim:mentions | umls-concept:C0555952 | lld:lifeskim |
pubmed-article:21165996 | lifeskim:mentions | umls-concept:C0027627 | lld:lifeskim |
pubmed-article:21165996 | lifeskim:mentions | umls-concept:C0796392 | lld:lifeskim |
pubmed-article:21165996 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
pubmed-article:21165996 | lifeskim:mentions | umls-concept:C1709059 | lld:lifeskim |
pubmed-article:21165996 | lifeskim:mentions | umls-concept:C0205460 | lld:lifeskim |
pubmed-article:21165996 | pubmed:issue | 8 | lld:pubmed |
pubmed-article:21165996 | pubmed:dateCreated | 2010-12-17 | lld:pubmed |
pubmed-article:21165996 | pubmed:abstractText | In the treatment of metastatic colorectal cancer, the subset of patients with liver-only metastases shows the greatest promise for prolonged survival and cure. Advances in surgery and medical treatment have encouraged multimodality treatment strategies and therefore require a true multidisciplinary approach. The current standard of care includes peri-operative chemotherapy and surgery. The new era of biologically targeted therapy requires an in-depth look at the possible efficacy and risks of adding these agents to the treatment protocol. | lld:pubmed |
pubmed-article:21165996 | pubmed:language | eng | lld:pubmed |
pubmed-article:21165996 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21165996 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21165996 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21165996 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21165996 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21165996 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21165996 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21165996 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21165996 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21165996 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21165996 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21165996 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21165996 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21165996 | pubmed:month | Dec | lld:pubmed |
pubmed-article:21165996 | pubmed:issn | 1096-9098 | lld:pubmed |
pubmed-article:21165996 | pubmed:author | pubmed-author:AertsRaymondR | lld:pubmed |
pubmed-article:21165996 | pubmed:author | pubmed-author:Van... | lld:pubmed |
pubmed-article:21165996 | pubmed:author | pubmed-author:PrenenHansH | lld:pubmed |
pubmed-article:21165996 | pubmed:author | pubmed-author:GevaRavitR | lld:pubmed |
pubmed-article:21165996 | pubmed:author | pubmed-author:TopalBakiB | lld:pubmed |
pubmed-article:21165996 | pubmed:author | pubmed-author:VannooteJaark... | lld:pubmed |
pubmed-article:21165996 | pubmed:copyrightInfo | © 2010 Wiley-Liss, Inc. | lld:pubmed |
pubmed-article:21165996 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21165996 | pubmed:day | 15 | lld:pubmed |
pubmed-article:21165996 | pubmed:volume | 102 | lld:pubmed |
pubmed-article:21165996 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21165996 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21165996 | pubmed:pagination | 937-45 | lld:pubmed |
pubmed-article:21165996 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:21165996 | pubmed:meshHeading | pubmed-meshheading:21165996... | lld:pubmed |
pubmed-article:21165996 | pubmed:meshHeading | pubmed-meshheading:21165996... | lld:pubmed |
pubmed-article:21165996 | pubmed:meshHeading | pubmed-meshheading:21165996... | lld:pubmed |
pubmed-article:21165996 | pubmed:meshHeading | pubmed-meshheading:21165996... | lld:pubmed |
pubmed-article:21165996 | pubmed:meshHeading | pubmed-meshheading:21165996... | lld:pubmed |
pubmed-article:21165996 | pubmed:meshHeading | pubmed-meshheading:21165996... | lld:pubmed |
pubmed-article:21165996 | pubmed:meshHeading | pubmed-meshheading:21165996... | lld:pubmed |
pubmed-article:21165996 | pubmed:meshHeading | pubmed-meshheading:21165996... | lld:pubmed |
pubmed-article:21165996 | pubmed:meshHeading | pubmed-meshheading:21165996... | lld:pubmed |
pubmed-article:21165996 | pubmed:meshHeading | pubmed-meshheading:21165996... | lld:pubmed |
pubmed-article:21165996 | pubmed:meshHeading | pubmed-meshheading:21165996... | lld:pubmed |
pubmed-article:21165996 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:21165996 | pubmed:articleTitle | Biologic modulation of chemotherapy in patients with hepatic colorectal metastases: the role of anti-VEGF and anti-EGFR antibodies. | lld:pubmed |
pubmed-article:21165996 | pubmed:affiliation | Department of Digestive Oncology, University Hospital Gasthuisberg, Leuven, Belgium. | lld:pubmed |
pubmed-article:21165996 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21165996 | pubmed:publicationType | Review | lld:pubmed |